tobi podhaler
viatris healthcare limited - tobramycin - cystic fibrosis; respiratory tract infections - antibacterials for systemic use, - tobi podhaler is indicated for the suppressive therapy of chronic pulmonary infection due to pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis. see sections 4.4 and 5.1 regarding data in different age groups.consideration should be given to official guidance on the appropriate use of antibacterial agents.
vantobra
pari pharma gmbh - tobramycin - cystic fibrosis; respiratory tract infections - antibacterials for systemic use, , aminoglycoside antibacterials - vantobra is indicated for the management of chronic pulmonary infection due to pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis (cf).consideration should be given to official guidance on the appropriate use of antibacterial agents.
methofill
accord healthcare limited - solution for injection - 7.5 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 10 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 12.5 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 15 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 17.5 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 20 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 22.5 milligram - methotrexate
methofill
accord healthcare limited - solution for injection - 25 milligram - methotrexate